Homocysteine Blood Test: What Elevated Levels Really Mean

Homocysteine is metabolised through two pathways: remethylation back to methionine (requires B12 and folate) and transsulphuration to cysteine (requires B6). Any block in these pathways elevates homocysteine. The most common causes of modestly elevated homocysteine are simple B12, folate, or B6 deficiency. Chronic kidney disease reduces homocysteine clearance and often produces mild-moderate elevation. Hypothyroidism does the same via slowed metabolism.

The MTHFR C677T variant (present in ~10% of Caucasians homozygously) reduces methylenetetrahydrofolate reductase activity and modestly raises homocysteine — typically 1–3 µmol/L above baseline. Homozygous cystathionine β-synthase (CBS) mutations cause classical homocystinuria — a rare paediatric metabolic disease with very high homocysteine (> 100), skeletal abnormalities, thromboembolism, and mental retardation if untreated.

Not routinely for cardiovascular risk. AHA, ESC, and NLA guidelines have all downgraded homocysteine as a routine screening test because randomised vitamin-lowering trials failed to translate the observational association into meaningful event reduction, especially for myocardial infarction. Stroke reduction with high-dose B-vitamins is modest (roughly 10% relative risk reduction) and mostly seen in populations with prior stroke and folate deficiency.

Homocysteine remains useful in specific settings: (1) suspected B12 or folate deficiency where the serum values are borderline (elevated homocysteine + elevated methylmalonic acid confirms B12 deficiency); (2) suspected homocystinuria — thromboembolism in a young person, lens dislocation, unusual skeletal features; (3) pre-eclampsia risk assessment in specific research settings.

Start with the workable causes: check B12, folate, TSH, and creatinine. Replace any deficiency (B12 injections or oral in absorption-preserved cases; folic acid 400–1000 mcg/day; treat hypothyroidism). Recheck homocysteine in 8–12 weeks — most modest elevations normalise once B-vitamins are corrected.

If homocysteine is severely elevated (> 50 µmol/L in an otherwise well adult, or > 100 in a young patient with thromboembolism or unusual features), refer to metabolic medicine to exclude homocystinuria. If homocysteine remains high after B-vitamin replacement and correction of CKD, further supplementation is not routinely helpful — it lowers the number without a reliable cardiovascular payoff.